(Q34865641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23886027%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23886027%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

0 references

1 reference

1 reference

25 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23886027%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23886027%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23886027%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23886027%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1186/1471-244x-13-196

6 March 2020

exact match

0 references

cites work

N-acetylcysteine for treatment of autism, a case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Targeting the mitochondrial electron transport chain in autism, a systematic review and synthesis of a novel therapeutic approach

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Targeting Mitochondria by Olesoxime or Complement 1q Binding Protein as a Novel Management for Autism: A Hypothesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Oxidative stress-related biomarkers in autism: systematic review and meta-analyses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Global prevalence of autism and other pervasive developmental disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Plasma antioxidant capacity is reduced in Asperger syndrome.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

A clinical trial of glutathione supplementation in autism spectrum disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

The conundrums of understanding genetic risks for autism spectrum disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Could fever and neuroinflammation play a role in the neurobiology of autism? A subject worthy of more research

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Glutathione pathway gene variation and risk of autism spectrum disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Methionine sulfoximine may improve inflammation in autism, a novel hypothesized treatment for autism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

The neurobiology of autism

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Risperidone in children with autism and serious behavioral problems

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

The rising prevalence of autism: a prospective longitudinal study in the Faroe Islands.

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

A preliminary study on screening prevalence of pervasive developmental disorder in schoolchildren in Iran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

A national study of the prevalence of autism among five-year-old children in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Oxidative stress in Rett syndrome: natural history, genotype, and variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Oxidative stress may mediate association of stereotypy and immunity in autism, a novel explanation with clinical and research implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Increased markers of oxidative stress in autistic children of the Sultanate of Oman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Increased excretion of a lipid peroxidation biomarker in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Urinary oxidative stress markers in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Brain region-specific glutathione redox imbalance in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

A functional transsulfuration pathway in the brain links to glutathione homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Neurodevelopmental disorders: Glutamate blockers show benefit in models of autism spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

c-Kit+ cells transplantation as a new treatment for autism, a novel hypothesis with important research and clinical implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

Last observation carry-forward and last observation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-196

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3737121

The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23886027

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-244X-13-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23886027%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 March 2020

1017772269

0 references

Fatcat ID

release_plav463ivzew5doy2moodhc3zu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/plav463ivzew5doy2moodhc3zu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23886027%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

23886027

1 reference